Litigation Details for Forest Laboratories LLC v. Accord Healthcare Inc. (D. Del. 2015)

✉ Email this page to a colleague

The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2016-11-21	105		.S. Patent Nos. 7,834,020 ("the '020 patent"), 8,193,195 ("the '195 patent"…that because claim 1 of U.S. Patent No. 7,834,020, claim 1 of U.S. Patent No. 8,236,804, and claims 5,… ORDER CONSTRUING THE TERMS of U.S. Patent Nos. 7,834,020, 8,193,195, 8,236,804, and 8,673,921. Signed…CONSTRUING THE TERMS OF U.S. PATENT NOS. 7,834,020, 8,193,195, 8,236,804, AND 8,673,921 …in the patent. '020 patent, col. 27 ll.42-43; '804 patent, col. 28, 1. 1; '921 patent, col.	External link to document
2015-03-27	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,834,020; 8,193,195; 8,236,804… 27 March 2015 1:15-cv-00272-GMS Patent None District Court, D. Delaware	External link to document
2016-06-22	86		other disorders. The patents-in-suit are U.S. Patent Nos. 7,834,020 (the “ ’020 patent”), 8,193,195 (the…the “ ’195 patent”), 8,236,804 (the “ ’804 patent”), and 8,673,921 (the “ ’921 patent”). While Forest … the ’020 patent, claim 1 of the ’804 patent, and claims 5, 11, and 13 of the ’921 patent, “crystalline…admits that a prior art patent, U.S. Patent No. 5,532,241 (the “ ’241 patent”), discloses vilazodone …804 Patent. The PTO rejected claim 1 of the ’804 patent as anticipated by the ’241 patent. See	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document